expenses 5.51 0.65 15.32 2.95 4.86 747.69 12.37 419.32 Operational Profit 21.24 6.92 63.94 18.33 14.32 206.93 45.61 248.82 Share of profit (loss) of associate (34.10) 20.82 (35.59) 69.05 (54.92) (263.78

the 2022 Annual General Meeting of shareholders 25/02/2022 12:32 The calling the Annual General Meeting of Shareholders for 2022 and disposal of investment in associate (Edit) 24/02/2022 21:37 The

211 186 25 13.4% Interest and Tax expenses 36 42 (6) -14.3% Share of profit from associate and JV 68 31 37 119.4% Net Profit attributable to equity holders 315 123 192 156.1% Total Revenues Total

the liquidation of Solvay Biochemicals (Taixing) Limited were fully booked in 2017. 4. 93 MB loss on dilution on investment in an associate was recorded from the change in the Company’s ownership

13.1% comparing to 2018 mostly from higher transportation costs, aligning with the increase of sales volume. 3. In the same period of last year, 93 MB loss on dilution on investment in an associate was

important essence as follows: Operating Result Company’s Financial Statement in the Quarter 3/2019 has net profit amount to Baht 10.85 million or Baht 0.62 per share (2018 : at Baht 1.25 per share) compared

change in status of associate to subsidiary and other income from the collection from receivables 5.43 million baht. Separate financial statements Revenues 1. Revenues from Sales 5.07 Million Baht increase

million lower than the proportionate net fair value of the identifiable assets this as the change in status of associate to subsidiary and other income from the collection from receivables 5.43 million baht

essence as follows: Operating Result Company’s Financial Statement for the year 2019 has net profit amount to Baht 1.47 million or Baht 0.08 per share compared to the net loss of Baht 10.71 million in year

expenses 197 193 4 2.1% Interest and Tax expenses 28 36 (8) -22.2% Share of profit from associate and JV 109 31 78 251.6% Net Profit attributable to equity holders 224 146 78 53.4% Total Revenues Total